tiprankstipranks
Trending News
More News >
Globe Life (GL)
NYSE:GL
Advertisement

Globe Life (GL) AI Stock Analysis

Compare
567 Followers

Top Page

GL

Globe Life

(NYSE:GL)

Rating:74Outperform
Price Target:―
Globe Life's overall score reflects strong financial performance, particularly in revenue growth and profitability. However, technical indicators suggest potential short-term challenges, and valuation metrics indicate the stock is relatively undervalued. Earnings call insights highlight growth in premiums and net income but also underline risks in health margins and sales, leading to a balanced outlook.
Positive Factors
Business Model
Globe's unique business model, which includes captive agent distribution and a focus on lower-/middle-income consumers, helps insulate it from severe competitive pressures.
Stock Repurchase
The company repurchased more stock than anticipated, which may indicate confidence in future prospects.
Underwriting Income
Life underwriting income showed strong performance with 9% year-over-year growth.
Negative Factors
Health Underwriting
Health underwriting income was below forecasts, contributing to a weaker overall result.
Investigations
Recent DOJ, SEC, and EEOC investigations remain an overhang on the shares.
Operating Earnings
GL's operating EPS was below expectations, which could pressure the stock.

Globe Life (GL) vs. SPDR S&P 500 ETF (SPY)

Globe Life Business Overview & Revenue Model

Company DescriptionGlobe Life Inc. is a leading financial services holding company, primarily operating in the life and health insurance sectors. The company, through its subsidiaries, offers a range of insurance products, including life insurance, supplemental health insurance, and annuities. Globe Life focuses on providing affordable coverage options to middle-income families across the United States, leveraging direct-to-consumer marketing strategies and a network of independent agencies to reach its customer base.
How the Company Makes MoneyGlobe Life Inc. generates revenue primarily through the sale of life and health insurance products. The company's key revenue streams include premium income from policyholders and investment income generated from its portfolio of invested assets. Globe Life employs a direct-to-consumer marketing approach, minimizing reliance on traditional brokerage channels, which helps reduce distribution costs and maximize profitability. Additionally, the company benefits from a strong underwriting process, maintaining low policy lapse rates and ensuring stable long-term cash flow. Significant factors contributing to Globe Life's earnings include its focus on serving underserved markets, efficient cost management, and strategic investment decisions that enhance the return on its investment portfolio.

Globe Life Earnings Call Summary

Earnings Call Date:Jul 23, 2025
(Q2-2025)
|
% Change Since: 5.38%|
Next Earnings Date:Oct 22, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted several positive developments, including significant increases in net operating income, agent count growth, and strong share repurchase activity. However, there were notable challenges such as declines in net investment income, health underwriting margins, and sales in some segments. Despite these challenges, the company remains optimistic about future growth, driven by favorable mortality trends and strategic investments.
Q2-2025 Updates
Positive Updates
Increased Net Operating Income
Net operating income for the quarter was $271 million or $3.27 per share, an increase of 10% over the $2.97 per share from a year ago.
Life Insurance Premium Revenue Growth
Life Insurance operations saw premium revenue increase by 3% from the year-ago quarter to $840 million.
Agent Count Growth
Exclusive agencies increased average agent count from the first quarter to the second quarter, for a combined sequential growth rate of 6%, resulting in an average total agent count of 17,621 for the second quarter.
Investment Yields
Invested $263 million in investment-grade fixed maturities with an average yield of 6.44% and invested $68 million in commercial mortgage loans with an average expected cash return of approximately 9.7%.
Share Repurchase Program
Repurchased approximately 1.9 million shares of Globe Life common stock for a total cost of approximately $226 million at an average share price of $121.13.
Favorable Mortality Trends
Continued favorable mortality trends leading to remeasurement gains and a positive impact on earnings guidance.
Negative Updates
Decline in Net Investment Income
Net investment income was $282 million, down 1% from the year-ago quarter.
Health Underwriting Margin Decline
Health underwriting margin was down 2% to $98 million due primarily to higher obligations than the year-ago period at United American.
Direct to Consumer Life Premium Decline
Direct to Consumer life premiums were down 1% over the year-ago quarter to $246 million.
Decline in Liberty National Sales
Net life sales decreased 5% to $25 million, and net health sales were $8 million, down 2% from the year-ago quarter due to lower agent productivity.
Excess Investment Income Decline
Excess investment income was $35 million, down approximately $8 million from the year-ago quarter.
Company Guidance
During the Globe Life Inc. Second Quarter Earnings Release Call, several key metrics were discussed. Net income for the quarter was $253 million, or $3.05 per share, compared to $258 million, or $2.83 per share, a year ago. Net operating income was $271 million, or $3.27 per share, showing a 10% increase over the $2.97 per share from the previous year. The return on equity (ROE) was 18.8% on a GAAP basis, and 14.4% excluding accumulated other comprehensive income (AOCI). Book value per share excluding AOCI was $90.26 by the end of June, marking a 10% increase from the prior year. Life insurance premium revenue grew by 3% to $840 million, while the underwriting margin increased by 6% to $340 million. Health insurance premium revenue rose by 8% to $378 million, but the underwriting margin decreased by 2% to $98 million. Administrative expenses were $86 million, representing a 5% increase over the prior year. The company anticipates a 4% increase in administrative expenses for the year, accounting for about 7.3% of premium. The guidance for the full year 2025 estimates net operating earnings per diluted share to be between $14.25 and $14.65, reflecting a 17% growth at the midpoint.

Globe Life Financial Statement Overview

Summary
Globe Life is performing well financially with consistent revenue growth and strong profitability. The balance sheet reflects stability with low leverage, although declining equity is a concern. Cash flow remains robust, supporting operations and potential investments.
Income Statement
85
Very Positive
Globe Life has shown consistent revenue growth over the years, with a noticeable increase from 2023 to 2024. The net profit margin in 2024 was strong at approximately 18.5%, indicating efficient cost management and profitability. However, the absence of EBIT and EBITDA data for 2024 limits a complete analysis of operational efficiency.
Balance Sheet
75
Positive
The company exhibits a sound equity position with a debt-to-equity ratio of 0.078, indicating low leverage risk. The equity ratio of approximately 18.2% in 2024 suggests financial stability. However, the decrease in stockholders' equity over the years could be a concern if it continues.
Cash Flow
80
Positive
The cash flow position is robust with a stable operating cash flow. The free cash flow has been consistent, although the growth rate reduced from 2022 to 2023. The free cash flow to net income ratio suggests a strong ability to generate cash relative to net income.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.78B5.45B5.21B5.11B4.74B
Gross Profit2.47B5.10B4.86B4.79B4.44B
EBITDA1.45B0.000.001.02B0.00
Net Income1.07B970.75M894.39M744.96M731.77M
Balance Sheet
Total Assets29.08B28.05B25.54B29.77B29.05B
Cash, Cash Equivalents and Short-Term Investments250.36M103.16M16.71B21.47B21.42B
Total Debt2.74B2.12B2.08B2.03B1.92B
Total Liabilities23.77B23.56B20.64B21.13B20.28B
Stockholders Equity5.31B4.49B4.90B8.64B8.77B
Cash Flow
Free Cash Flow1.33B1.43B1.39B1.40B1.43B
Operating Cash Flow1.40B1.48B1.42B1.44B1.48B
Investing Cash Flow-641.52M-926.15M-943.01M-913.37M-1.18B
Financing Cash Flow-715.84M-541.49M-492.45M-523.60M-274.06M

Globe Life Technical Analysis

Technical Analysis Sentiment
Positive
Last Price131.52
Price Trends
50DMA
121.04
Positive
100DMA
122.29
Positive
200DMA
117.17
Positive
Market Momentum
MACD
1.12
Negative
RSI
68.97
Neutral
STOCH
94.55
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GL, the sentiment is Positive. The current price of 131.52 is above the 20-day moving average (MA) of 121.74, above the 50-day MA of 121.04, and above the 200-day MA of 117.17, indicating a bullish trend. The MACD of 1.12 indicates Negative momentum. The RSI at 68.97 is Neutral, neither overbought nor oversold. The STOCH value of 94.55 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GL.

Globe Life Risk Analysis

Globe Life disclosed 23 risk factors in its most recent earnings report. Globe Life reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Globe Life Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$10.30B10.1620.47%0.78%5.41%16.60%
74
Outperform
$13.95B9.5214.68%2.15%1.69%25.54%
73
Outperform
$8.68B18.0523.90%1.47%10.18%-9.75%
70
Outperform
$4.30B8.6212.72%2.73%-1.72%95.91%
69
Neutral
$6.39B87.171.24%3.35%3.55%8.91%
68
Neutral
$17.10B11.629.70%3.86%11.32%-7.37%
65
Neutral
$5.93B5.0116.91%5.18%8.31%-2.30%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GL
Globe Life
131.52
43.21
48.93%
LNC
Lincoln National
34.72
4.00
13.02%
PRI
Primerica
264.13
17.37
7.04%
UNM
Unum Group
80.01
27.97
53.75%
JXN
Jackson Financial Incorporation
87.62
5.24
6.36%
FG
F&G Annuities & Life Inc
31.88
-10.76
-25.23%

Globe Life Corporate Events

Executive/Board Changes
Globe Life Introduces Executive Severance Plan
Neutral
Nov 19, 2024

Globe Life Inc.’s Board of Directors has introduced the Executive Severance Plan, offering severance benefits to key executives, including Co-CEOs, in cases of employment termination without cause or for good reason. The plan provides cash severance based on salary and bonuses, along with support for health plans and future employment assistance. Amendments to stock options and performance shares ensure vesting aligns with termination conditions, protecting executives during changes in control. Compliance with confidentiality and other provisions is required to maintain benefits.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 02, 2025